BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36171027)

  • 1. Prenatal marijuana exposure and neonatal outcomes: a retrospective cohort study.
    Jones MJ; Lotfi A; Lin A; Gievers LL; Hendrickson R; Sheridan DC
    BMJ Open; 2022 Sep; 12(9):e061167. PubMed ID: 36171027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal outcomes associated with in utero cannabis exposure: a population-based retrospective cohort study.
    Avalos LA; Adams SR; Alexeeff SE; Oberman NR; Does MB; Ansley D; Goler N; Padon AA; Silver LD; Young-Wolff KC
    Am J Obstet Gynecol; 2024 Jul; 231(1):132.e1-132.e13. PubMed ID: 38029850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marijuana use in opioid exposed pregnancy increases risk of preterm birth.
    Shah DS; Turner EL; Chroust AJ; Duvall KL; Wood DL; Bailey BA
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8456-8461. PubMed ID: 34582287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth Outcomes of Neonates Exposed to Marijuana in Utero: A Systematic Review and Meta-analysis.
    Marchand G; Masoud AT; Govindan M; Ware K; King A; Ruther S; Brazil G; Ulibarri H; Parise J; Arroyo A; Coriell C; Goetz S; Karrys A; Sainz K
    JAMA Netw Open; 2022 Jan; 5(1):e2145653. PubMed ID: 35084479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal and infant cannabis testing and associated birth outcomes.
    Mark K; Crimmins S
    Arch Gynecol Obstet; 2024 May; 309(5):1903-1907. PubMed ID: 37166490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity.
    Metz TD; Allshouse AA; Hogue CJ; Goldenberg RL; Dudley DJ; Varner MW; Conway DL; Saade GR; Silver RM
    Am J Obstet Gynecol; 2017 Oct; 217(4):478.e1-478.e8. PubMed ID: 28578174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis.
    Gunn JK; Rosales CB; Center KE; Nuñez A; Gibson SJ; Christ C; Ehiri JE
    BMJ Open; 2016 Apr; 6(4):e009986. PubMed ID: 27048634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis Use Based on Urine Drug Screens in Pregnancy and Its Association With Infant Birth Weight.
    Howard DS; Dhanraj DN; Devaiah CG; Lambers DS
    J Addict Med; 2019; 13(6):436-441. PubMed ID: 30908346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The associations between prenatal cannabis use disorder and neonatal outcomes.
    Shi Y; Zhu B; Liang D
    Addiction; 2021 Nov; 116(11):3069-3079. PubMed ID: 33887075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Marijuana Legalization in Oklahoma: Effects on Neonatal Exposure to Opiates.
    DeShea L; Rolfs S; McCoy M; Beasley WH; Szyld E; Makkar A
    Am J Perinatol; 2024 May; 41(S 01):e1069-e1074. PubMed ID: 36452967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth outcomes following in utero co-exposure to tobacco and marijuana.
    Waddell ML; Dickson SA; Dodge PA; Kopkau HE; Nadolski KN; Zablocki V; Forrestal KM; Bailey BA
    Birth Defects Res; 2024 Jan; 116(1):e2272. PubMed ID: 37947014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Maternal Opioid Use in Pregnancy With Adverse Perinatal Outcomes in Ontario, Canada, From 2012 to 2018.
    Corsi DJ; Hsu H; Fell DB; Wen SW; Walker M
    JAMA Netw Open; 2020 Jul; 3(7):e208256. PubMed ID: 32725246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis Use During the Perinatal Period in a State With Legalized Recreational and Medical Marijuana: The Association Between Maternal Characteristics, Breastfeeding Patterns, and Neonatal Outcomes.
    Crume TL; Juhl AL; Brooks-Russell A; Hall KE; Wymore E; Borgelt LM
    J Pediatr; 2018 Jun; 197():90-96. PubMed ID: 29605394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of environmental tobacco smoke on perinatal outcomes: a retrospective cohort study.
    Crane JM; Keough M; Murphy P; Burrage L; Hutchens D
    BJOG; 2011 Jun; 118(7):865-71. PubMed ID: 21426481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy.
    Kharbanda EO; Vazquez-Benitez G; Kunin-Batson A; Nordin JD; Olsen A; Romitti PA
    J Perinatol; 2020 Mar; 40(3):473-480. PubMed ID: 31911642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal drug use in Minneapolis-St Paul, Minn. A 4-year trend.
    Yawn BP; Thompson LR; Lupo VR; Googins MK; Yawn RA
    Arch Fam Med; 1994 Jun; 3(6):520-7. PubMed ID: 8081532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes.
    Corsi DJ; Walsh L; Weiss D; Hsu H; El-Chaar D; Hawken S; Fell DB; Walker M
    JAMA; 2019 Jul; 322(2):145-152. PubMed ID: 31211826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth.
    Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
    Pediatrics; 1998 Feb; 101(2):229-37. PubMed ID: 9445496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth.
    Gray TR; Eiden RD; Leonard KE; Connors GJ; Shisler S; Huestis MA
    Clin Chem; 2010 Sep; 56(9):1442-50. PubMed ID: 20628142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes.
    Mark K; Desai A; Terplan M
    Arch Womens Ment Health; 2016 Feb; 19(1):105-11. PubMed ID: 25895138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.